GLP-1 receptor agonist
Generic name: liraglutide
US Retail Price
$900–$1,000/month
With copay card: As low as $99/month (commercially insured)
Manufacturer
Novo Nordisk
Used For
Type 2 diabetes management; also used off-label for weight loss (brand Saxenda is the weight-loss version)
Victoza (liraglutide) is an older GLP-1 agonist that has been largely superseded by semaglutide (Ozempic/Wegovy) for both diabetes and weight loss. Generic liraglutide is not yet available in the US. Novo Nordisk offers a savings card for commercially insured patients.
Novo Nordisk's Victoza savings card can reduce costs to as low as $99/month for commercially insured patients. Not available for Medicare/Medicaid. Enroll through the NeedyMeds copay card search.
Find Victoza Savings CardVictoza is available from verified international pharmacies in Canada and other countries at 60–75% less than US retail prices. Use PharmacyChecker to compare verified international sources.
Compare International PricesNovo Nordisk's NovoCare patient assistance program may provide free Victoza for qualifying low-income patients who meet income and insurance eligibility criteria.
Search NeedyMedsGoodRx coupons can reduce Victoza costs at US pharmacies. Savings are modest compared to the savings card but useful for patients who don't qualify for the manufacturer program.
Check GoodRx PriceLooking for another medication?
The Med Map covers all 8 categories of savings options for hundreds of drugs.
Back to The Med Map